Arcutis Net Tangible Assets from 2010 to 2024

ARQT Stock  USD 11.71  0.20  1.74%   
Arcutis Biotherapeutics Net Tangible Assets yearly trend continues to be comparatively stable with very little volatility. Net Tangible Assets will likely drop to about 124.1 M in 2024. Net Tangible Assets is the total assets of Arcutis Biotherapeutics minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. View All Fundamentals
 
Net Tangible Assets  
First Reported
2010-12-31
Previous Quarter
232.8 M
Current Value
124.1 M
Quarterly Volatility
122.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Arcutis Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcutis Biotherapeutics' main balance sheet or income statement drivers, such as Interest Expense of 31.2 M, Selling General Administrative of 182.2 M or Total Revenue of 62.6 M, as well as many indicators such as Price To Sales Ratio of 3.57, Dividend Yield of 0.0 or PTB Ratio of 2.65. Arcutis financial statements analysis is a perfect complement when working with Arcutis Biotherapeutics Valuation or Volatility modules.
  
Check out the analysis of Arcutis Biotherapeutics Correlation against competitors.
For more information on how to buy Arcutis Stock please use our How to Invest in Arcutis Biotherapeutics guide.

Latest Arcutis Biotherapeutics' Net Tangible Assets Growth Pattern

Below is the plot of the Net Tangible Assets of Arcutis Biotherapeutics over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Arcutis Biotherapeutics' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcutis Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
Net Tangible Assets10 Years Trend
Slightly volatile
   Net Tangible Assets   
       Timeline  

Arcutis Net Tangible Assets Regression Statistics

Arithmetic Mean66,569,421
Geometric Mean23,095,098
Coefficient Of Variation184.38
Mean Deviation105,953,895
Median(4,993,000)
Standard Deviation122,738,243
Sample Variance15064.7T
Range362.7M
R-Value0.69
Mean Square Error8607.4T
R-Squared0.47
Significance0
Slope18,804,340
Total Sum of Squares210905.5T

Arcutis Net Tangible Assets History

2024124.1 M
2023232.8 M
2022202.4 M
2021297.7 M
2020270.6 M
2019-65 M
2018-24 M

About Arcutis Biotherapeutics Financial Statements

Arcutis Biotherapeutics shareholders use historical fundamental indicators, such as Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Arcutis Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Arcutis Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcutis Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Tangible Assets232.8 M124.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcutis Stock Analysis

When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.